|
We received an order from
Company B in Spain for 4 Anyfusion cylinder pumps V100 and H100 and 2 Anyfusion
ACPi systems for demonstration purposes.
Company B has been exporting
EZ Regular to Colombia for more than 15 years and has built a strong
relationship with the company. As a result of the direct introduction of
Anyfusion (pump and ACPi) as a product at the German MEDICA in November 2022,
and knowing the competitiveness of Anyfusion accurately, we conducted product
explanation and demo in many hospitals in Madrid, the representative city of
western Spain (Andalusia), and Barcelona, the representative city of eastern
Spain (Catalonia), from June 12 to June 20.
The market demand for the
Anyfusion ACPi system, which is the only technology product from dispensing to
injecting, is quite high, and we have decided to import the first ACPi overseas
for the first time, because it is dangerous, difficult and laborious to
dispense anti-cancer (injection) drugs, which had no alternative but human
dispensing, in a sterile room with thorough safety clothes and clean bench due
to toxicity and risk of infection than pumps with alternative products. The
ACPi system is a multifunctional product that can be used for dispensing only,
dispensing to infusion, as well as filling TPN and PCA balloons, with high
safety and efficacy and reasonable cost-effectiveness, and explosive demand is
expected once user convenience is confirmed. In domestic hospitals, we learned
that there are frequent safety accidents of leakage of anti-cancer drugs due to
free flow caused by carelessness when injecting and finishing with conventional
pumps, and we also learned that Anyfusion cartridge technology does not
fundamentally cause such safety accidents, as recognized by the FDA.
Company B is a company that
demands exclusivity for Anyfusion in Europe and South America, and the results
of this demonstration will be of great significance and reference to the global
market, which is a patient-centered medical culture that values safety and
efficacy, and will be an important opportunity for the globalization of
Anyfusion.
We sincerely appreciate the
efforts of Spain B. |
